dorsaVi reveals that integrating RRAM and neuromorphic computing into its sensor platform could halve sensor count and more than double battery life in lower-limb exoskeletons, positioning the company as a key intelligence partner in a $1.79 billion market.
- RRAM and neuromorphic integration cuts sensor count by 25–50%
- Wireless data volume reduced up to 100-fold
- Battery life improved by over 2 times
- Existing sensors support gait intent and fatigue monitoring
- Exoskeleton market projected to reach US$1.79 billion by 2033
Neuromorphic Sensors Set to Revolutionise Exoskeleton Intelligence
dorsaVi Limited (ASX:DVL) has outlined a strategic leap in wearable robotics, announcing that its resistive random-access memory (RRAM) and neuromorphic computing roadmap could more than double battery life in lower-limb exoskeletons while slashing sensor counts by up to half. This shift from raw data streaming to in-sensor decision-making promises to cut wireless data transmission by up to 100 times, enabling real-time, low-latency control without reliance on cloud connectivity.
The company’s existing electromyography (EMG) and movement sensors already underpin key exoskeleton functions such as gait intent detection, fatigue monitoring, and supervisory control. But the integration of RRAM and neuromorphic processing transforms these devices from passive data collectors into active, intelligent nodes capable of local filtering, feature extraction, and event detection within milliseconds.
Positioning at the Sensor-Intelligence Layer
Rather than building exoskeleton hardware, dorsaVi aims to embed its sensor intelligence into the control loops of wearable robotics. This approach targets the critical challenge in exoskeleton technology: anticipating user movement intent before it happens. By capturing muscle electrical activity that precedes motion, dorsaVi’s sensors can inform exoskeletons what the wearer intends to do, enabling smoother, more adaptive assistance.
This sensor-intelligence layer strategy opens diverse revenue streams including direct sensor sales, OEM integration, licensing of sensor algorithms, validation services for clinical and industrial trials, and recurring software subscriptions. It positions dorsaVi as a partner to exoskeleton manufacturers rather than a competitor, broadening its commercial footprint across healthcare, defence, industrial, and aged care sectors.
Staged Deployment Path Balances Coverage and Practicality
dorsaVi’s analysis defines a phased sensor configuration pathway starting with eight sensors for comprehensive bilateral lower-limb mapping, reducing to 4–6 sensors for real-time supervisory control, and simplifying to four EMG plus one motion sensor for field validation. This progression balances signal fidelity with deployment complexity and commercial readiness.
Future RRAM–neuromorphic smart sensors are projected to achieve decision latencies below 10–30 milliseconds and classification accuracy above 90%, critical for integration into closed-loop exoskeleton control. The anticipated sensor count reduction stems from localised feature extraction and event detection, which reduces redundant raw data channels.
Commercial Outlook and Market Opportunity
The global exoskeleton market is forecast to reach US$1.79 billion by 2033, driven by demand in medical rehabilitation, industrial safety, defence, and aged care. dorsaVi’s Ultra-Edge Modular Design and Build program is advancing the translation of its RRAM and neuromorphic IP into manufacturable hardware platforms designed for ultra-low power consumption, targeting coin-cell battery operation.
Alongside hardware development, the company is validating neuromorphic sensing and signal interface technologies that convert real-world biological and environmental inputs into actionable data. These efforts underpin dorsaVi’s ambition to become a core component of next-generation exoskeletons, prosthetics, and rehabilitation robotics.
Group CEO Mathew Regan emphasised that the existing FDA-cleared sensor platform already enables meaningful participation in the exoskeleton market today, with the RRAM–neuromorphic roadmap set to elevate dorsaVi’s role from valuable to decisive. The company plans to update shareholders on commercial progress and partnerships in the coming months, signaling a deliberate build towards embedding intelligence at the ultra-edge of wearable robotics.
Bottom Line?
dorsaVi’s neuromorphic sensor upgrade could redefine exoskeleton control by delivering smarter, leaner, and longer-lasting wearable intelligence.
Questions in the middle?
- How quickly will dorsaVi’s RRAM-neuromorphic sensors move from lab validation to commercial deployment?
- Which exoskeleton manufacturers will partner with dorsaVi to integrate its sensor intelligence?
- What competitive responses might emerge as sensor intelligence becomes a key differentiator in wearable robotics?